OBLIQUE THERAPEUTICS Trademark

Trademark Overview

On Thursday, November 1, 2018, a trademark application was filed for OBLIQUE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OBLIQUE THERAPEUTICS trademark a serial number of 88178266. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 3, 2023. This trademark is owned by Oblique Therapeutics AB. The OBLIQUE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

medicines and pharmaceutical preparations for the treatment of diseases with a high unmet clinical need, namely, cancer, diabetes and pain related diseases; Medicines for the treatment of cancer, diabetes and pain related diseases; Anti-cancer preparations of microbial origin; Anti-cancer preparations of chemical origin; Biological preparations for the treatment of cancer, diabetes and pain related diseases
oblique therapeutics

General Information

Serial Number88178266
Word MarkOBLIQUE THERAPEUTICS
Filing DateThursday, November 1, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2020

Trademark Statements

Goods and Servicesmedicines and pharmaceutical preparations for the treatment of diseases with a high unmet clinical need, namely, cancer, diabetes and pain related diseases; Medicines for the treatment of cancer, diabetes and pain related diseases; Anti-cancer preparations of microbial origin; Anti-cancer preparations of chemical origin; Biological preparations for the treatment of cancer, diabetes and pain related diseases
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 16, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOblique Therapeutics AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address413 46 Göteborg 41346
SE
Party NameOblique Therapeutics AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address413 46 Göteborg
SE

Trademark Events

Event DateEvent Description
Monday, April 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 7, 2022SOU EXTENSION 5 GRANTED
Thursday, August 25, 2022SOU EXTENSION 5 FILED
Wednesday, September 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 25, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 25, 2022SOU EXTENSION 4 GRANTED
Friday, February 25, 2022SOU EXTENSION 4 FILED
Friday, February 25, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 30, 2021SOU EXTENSION 3 GRANTED
Monday, August 30, 2021SOU EXTENSION 3 FILED
Monday, August 30, 2021SOU TEAS EXTENSION RECEIVED
Thursday, March 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 2, 2021SOU EXTENSION 2 GRANTED
Tuesday, March 2, 2021SOU EXTENSION 2 FILED
Tuesday, March 2, 2021SOU TEAS EXTENSION RECEIVED
Friday, May 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 29, 2020SOU EXTENSION 1 GRANTED
Wednesday, April 29, 2020SOU EXTENSION 1 FILED
Wednesday, April 29, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 4, 2019ASSIGNED TO LIE
Monday, December 2, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 26, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 3, 2019NON-FINAL ACTION E-MAILED
Monday, June 3, 2019NON-FINAL ACTION WRITTEN
Monday, May 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 20, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 7, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 7, 2019NON-FINAL ACTION E-MAILED
Thursday, February 7, 2019NON-FINAL ACTION WRITTEN
Thursday, February 7, 2019ASSIGNED TO EXAMINER
Friday, November 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 5, 2018NEW APPLICATION ENTERED

Related Keywords

therapeutics oblique cancer diseases preparations diabetes related treatment pain medicines origin anti